In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. Read More
CSL Facility on the Front Line of Flu Fight
The Kankakee, IL facility and its flu vaccine preparations were the feature of a recent Chicago news program.
Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older
This is the first four-strain, cell ...
Seqirus Honored with National Award for Outstanding Efforts in Influenza Prevention
The accolade recognizes Seqirus’ creative and ...
Seqirus receives FDA approval for FLUAD™ (Influenza Vaccine, Adjuvanted) for adults aged 65 years and older
Fluad is the first adjuvanted seasonal ...
Search Career Opportunities
At Seqirus, each employee has the opportunity to play a role in improving people's health.